ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies
TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing...
Copyright Enforcement Dialogue 2026 in Taipei Reinforces Regional Public-Private Cooperation Against Digital Piracy
TAIPEI, April 23, 2026 /PRNewswire/ -- On April 22, 2026, the Motion Picture Association (MPA) Asia Pacific concluded the Copyright Enforcement Dialogue: Taipei 2026, convening senior policymakers, law enforcement authorities, judicial...
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
SHANGHAI, April 22, 2026 /PRNewswire/ -- Hengrui Pharma reported steady growth in the first quarter of 2026. In Q1 2026, the Company recorded revenue of RMB 8.14 billion, up 12.98% year-over-year, while net profit attributable to shareholders...
Xinhua Silk Road: Traceability & anti-counterfeiting help ensure reliable quality of green tea in Rizhao
BEIJING, April 14, 2026 /PRNewswire/ -- In Rizhao, one of the world's three major coastal green tea cities, a complete tea industry chain traceability and anti-counterfeiting system is helping the eastern China locality ensure superb quality of...
VEVOR and Rebuilding Together Houston Restore a Legacy Home, One Solution at a Time
HOUSTON, April 3, 2026 /PRNewswire/ -- For Regina Walker, a breast cancer survivor in Houston's South Union community, her 75-year-old legacy home represents three generations of family memories. However, time and financial hardship had taken a...
Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
WILMINGTON, Del., April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase IIa clinical trial of HXN-1001, a half-life extended...
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
WILMINGTON, Del., March 20, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised $787 million in financing rounds. The investment included participation by a...
Globe Teleservices Announces Partnership with Myanma Posts and Telecommunications to Enhance Secure Messaging and Customer Experience
SINGAPORE, March 11, 2026 /PRNewswire/ -- Globe Teleservices Pte. Ltd. (GTS), a global telecom solutions provider, announced its partnership with Myanma Posts and Telecommunications (MPT Myanmar), Myanmar's state-owned telecommunications operator,...
DoveRunner Expands Presence in Southeast Asia with New Office in Jakarta
JAKARTA, Indonesia, Feb. 25, 2026 /PRNewswire/ -- DoveRunner, a global leader in mobile application protection and content security technology, has announced the opening of its new office in Jakarta, Indonesia. This expansion reinforces DoveRunner's...
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful...